Inogen (INGN)
(Delayed Data from NSDQ)
$7.67 USD
-0.16 (-2.04%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $7.68 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INGN 7.67 -0.16(-2.04%)
Will INGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INGN
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
INGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound?
Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Other News for INGN
Inogen Annual Meeting: Strategic Direction and Governance Outcomes
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
Inogen publishes study linking portable oxygen concentrators, higher survival
Inogen Announces Executive Leadership Restructuring
Stifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)